REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/30/2026
Back to search
Official data from USPTO
IMMUNO Q-SERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNO Q-SERA
ST13
US500000088369995Class
5
Filing
88369995
Registration
6303671
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/31/2026
Trademark type
Word
Nice classes
5
Filing date
04/03/2019
Registration date
03/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/30/2021
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
TOKYO, JP
Examiner
ENGEL, MICHAEL
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DENKA COMPANY LIMITED
D. K. (pessoa física)
Representatives
Charles T. J. Weigell FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reference standard substances used for clinical tests for medical purposes; standard substances for clinical tests for calibrating medical devices and reagents; diagnostic protein reference standards; in vitro test reagents and control standards for medical diagnostic use; reference standard serum used for clinical tests for medical purposes; diagnostic reagents for medical purposes; diagnostic reagents for veterinary purposes; reagents for analytical purposes for medical and/or veterinary purposes
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/30/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/12/2021
PUBO
PUBLISHED FOR OPPOSITION
01/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/23/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/28/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/01/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/20/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/20/2019
GNSL
LETTER OF SUSPENSION E-MAILED
12/20/2019
CNSL
SUSPENSION LETTER WRITTEN
12/20/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2019
ALIE
ASSIGNED TO LIE
12/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/19/2019
GNRT
NON-FINAL ACTION E-MAILED
06/19/2019
CNRT
NON-FINAL ACTION WRITTEN
06/19/2019
DOCK
ASSIGNED TO EXAMINER
06/13/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/03/2019
ALIE
ASSIGNED TO LIE
04/26/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/22/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/20/2019
NWAP
NEW APPLICATION ENTERED
04/06/2019
Continuous trademark protection
Get notified about every new filing that threatens IMMUNO Q-SERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.